|
SRPK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.477200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.835800E-03 |
| Normal-vs-Stage2 |
3.659000E-01 |
| Normal-vs-Stage3 |
5.582800E-03 |
| Normal-vs-Stage4 |
1.001270E-03 |
| Stage1-vs-Stage2 |
2.798400E-01 |
| Stage1-vs-Stage3 |
5.357200E-01 |
| Stage1-vs-Stage4 |
1.871370E-01 |
| Stage2-vs-Stage3 |
1.499770E-01 |
| Stage2-vs-Stage4 |
6.405500E-02 |
| Stage3-vs-Stage4 |
4.567800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.735500E-03 |
| Normal-vs-AfricanAmerican |
5.226600E-01 |
| Normal-vs-Asian |
5.459600E-02 |
| Caucasian-vs-AfricanAmerican |
1.414030E-01 |
| Caucasian-vs-Asian |
7.248200E-01 |
| AfricanAmerican-vs-Asian |
3.089000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.716300E-03 |
| Normal-vs-Female |
9.318300E-03 |
| Male-vs-Female |
3.803200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.508060E-02 |
| Normal-vs-Age(41-60Yrs) |
8.382700E-03 |
| Normal-vs-Age(61-80Yrs) |
6.024200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.904500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.860800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.830600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.036000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.630200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.039000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.537200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.176600E-01 |
| Classical-VS-Follicular |
7.606800E-01 |
| Classical-VS-Other |
1.449360E-01 |
| Classical-VS-Normal |
1.201540E-02 |
| Tall-VS-Follicular |
3.375200E-01 |
| Tall-VS-Other |
2.650200E-01 |
| Tall-VS-Normal |
1.638420E-02 |
| Follicular-VS-Other |
2.035800E-01 |
| Follicular-VS-Normal |
9.647700E-02 |
| Other-VS-Normal |
1.911890E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.146270E-02 |
| Normal-vs-N1 |
1.178620E-03 |
| N0-vs-N1 |
1.819620E-01 |
|
|
